MichelleL.HermistonMDPhD

Pediatric Hematology & Oncology • San Francisco, CA

Director of the Pediatric Immunotherapy Program and Associate Professor Pediatrics at University of California San Francisco Benioff Children's Hospital

Request Appointment

Overview of Dr. Hermiston

Dr. Michelle Hermiston is a pediatric hematologist/oncologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Benioff Children's Hospital Oakland, UCSF Benioff Childrens Hospital, and Kaiser Permanente San Francisco Medical Center. She received her medical degree from Washington University in St. Louis School of Medicine and has been in practice 24 years. She is one of 19 doctors at UCSF Benioff Childrens Hospital and one of 55 doctors at UCSF Benioff Children's Hospital Oakland who specialize in Pediatric Hematology & Oncology. She has more than 50 publications and over 500 citings.

Office
505 Parnassus Ave
San Francisco, CA 94143
Book by Phone+1(855) 750-2599

Fax+1 415-353-2657

Education & Training

Washington University in St. LouisMedical Scientist Training Program, 2024 - 2024
University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 1999 - 2002
University of California (San Francisco)Residency, Pediatrics, 1997 - 1999
Washington University in St. Louis School of MedicineClass of 1997

Certifications & Licensure

CA State Medical License 1999 - 2026
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis Start of enrollment: 2016 Nov 02
Recruiting
Phase 2, Phase 3
Roles: Contact
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma Start of enrollment: 2019 Mar 01
Recruiting
Early Phase 1
Roles: Contact
Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis Start of enrollment: 2021 Jul 13
Recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Thrombopoietin Receptor Agonists for Thrombocytopenia in Pediatric Hematologic Malignancies.
Amanda E Marinoff, Allyson Thrall, Kathryn Aaronson, Benjamin S Braun, Maria Castellanos
Pediatric Blood & Cancer. 2025-03-01
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review St...
Shanmuganathan Chandrakasan, Carl E Allen, Deepika Bhatla, John Carter, May Chien
Arthritis & Rheumatology. 2024-09-08
Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic Microangiopathy.
Christine S Higham, Kristin A Shimano, Sandhya Kharbanda, Julia Chu, Gabriel Salinas Cisneros
Transplantation and Cellular Therapy. 2024-09-01

Press Mentions

UCSF Benioff Children’s Hospitals Rank Among the Nation’s Best for 10 Specialties in 2020-2021 U.S. News & World ReportJune 16th, 2020
Delivering Cellular and Gene Therapies to Patients: Solutions for Realizing the Potential of the Next Generation of MedicineApril 25th, 2020
Physicians’ Education Resource® to Host Satellite Symposia at Annual American Society of Hematology Meeting and Exposition in OrlandoNovember 7th, 2019
Join now to see all

Grant Support

Interplay Of Innate And Adaptive Immunity In Lupus PathogenesisNational Institute Of Allergy And Infectious Diseases2010–2011
Role Of CD45 In Hematopoiesis And LymphomagenesisNational Cancer Institute2003–2005

Professional Memberships

American Society of Clinical Oncology - ASCO
Member